SEC Filing Details

Document Details

Filing Date
Mar 21, 2024
Document Date
Mar 21, 2024
Form Description
S-3ASR
Filing Group
Registration Statements
Company
Denali Therapeutics
Issuer
Denali Therapeutics Inc.